您的浏览器禁用了JavaScript(一种计算机语言,用以实现您与网页的交互),请解除该禁用,或者联系我们。 [港股财报]:绿竹生物-B:2023年年度报告 - 发现报告

绿竹生物-B:2023年年度报告

2024-04-23 港股财报 故人
报告封面

股份代號: 2480(於中華人民共和國註冊成立的股份有限公司) 245682132484966108113114115116118169170 •8835 3212101-2105 (FCG HKFCG(PE)) 183401 (FCG HKFCG(PE)) 112-14 7 3 H 1617 13 2480 www.luzhubiotech.com 3 202358 3485 202220231231 2001 20231231LZ901 20231231LZ90120244 H202358H241.6 20231231 2023202358IPO2023 20235LZ901II20239IIIIII26,000202312BLA 20232LZ901I20237ILZ901 127.22,500L2,000 20231 2024 2024LZ901BLA Fabite®Fabite®TFabite®2-8˚C Fabite® LZ901 LZ901VZVVZVFcAPCLZ901VZVLZ901I 20235LZ901IILZ901GMCGMTLZ901GMCGMTAE0-7IIIIIIAE23.74%6.02%1.00%AE29.0%23.0%13.0%LZ901IIIVAEAE IIIII20239LZ901III2024LZ901BLA2025LZ901III50LZ901III402024126,0004020227FDALZ901IND2023220237LZ901I2024LZ901I K3 K3TNF-αHumira®20189IK3201912I2024K3III2025IIIK32026 K193 K193BBCD19CD193CD3K193CD19/CD3K193Fabite®K193K193BK193201912K193I2024I RSV20231231RSVK333K1932 (1)(2)RSV(3)K3II 2023123128 GMP2023123128GMP •LZ901K3K193•••• 202220231231 2022123113.944.3%2023123120.15.8 202212313.180.8%202312310.620221B+202212312.520231231 2022123115.120.3%2023123118.25.72.5 20221231551.52023123120226 2022123185.81.4%2023123187.011.7 2022123191.488.9%20231231172.7LZ901III 202212310.716.9%202312310.8 2022123121.522.8%2023123126.5 20221231725.265.6%20231231249.4 20231231 25%2022123120231231 20221231152.146.6%20231231222.9LZ901III 2022123169.0196.020231231265.0 202312317.02.35% 20231231 20231231 20231231 2023123112.5%2022123112.4% 202312312022123113.52023123149.820239 20231231 202383045,072.872023830 20231231 20231231 2023123120221231 H202358241.62023552023528 20231231 2023123113320231231 20231231 202413159,729,29659,729,296HH59,729,296H(i)20234251,434,783HH(ii)58,294,513H 20242521,185200.0 20231231 602002720089112022618 3571198810200220001020003 1985719889 6120022201372018ACACbACYW13520136282022618 3716ACEA 1984819981 612013628202261820041 38ACACYW135GMP198572004β20003 19857 602019822022618 2419998300485200172018220237 1989620081220171 492019822022618 2004720107201072011920119 20046201211 472023330 2020003200582007520101282620101295120131220162124720184HPC Holdings Limited1742 Coyoh Limited20096820141010Coyoh Limited744(3)Coyoh LimitedCoyoh LimitedCoyoh Limited 1998620101120021220035 742023330 341989 20021312013108 19889 582023330199232009112009201072018320187 19877 4320197192015420197201811201972020320211220224 2003720066 31201472120137 20136 44202242620218 20167201510201812 3720238202312 1320091220121220135201490005632014112017860121126112017920238 2008620095(NewYork University School of Law) 33202261820219 20152201510java201511202191024java 20136 4220214202112 142007720101120101120172013420171120214SPFCRO 2005720076 49202010 2319993200110Pfizer Asia Pacific Pte.Ltd.2006220074151300051320077201072010520112016920205 19977 57202112 331989720027200282016120874600332201718342982018102020320201020211120215202112 1989620026200112 2021912022618 2022121625 (HKCGI)(CGI) 13.51B(1) 20231231 2232 6225 (i)(ii)(iii)(iv)CRO 176.32022152.251.2%202280.3%73.32022127.121.3%202267.1%5% 20231231 ••••••• •••• ••• ••• •••• •••• •••••• ••••• •• 1993045201134810%H2008897H10%HH 2131 15 27 2023123125 2022 38 202312312022 1112 3.25C1 111234 20231231 20231231XVXV78352 (i) (1)(2)(3)20231231(4)20231231(i)34.00%46.00%(ii)60.00%80.00%(i)(ii)(iii)(iv)(5)2023123149.51%(6)40.67%(i)(ii)(7)H20231231202,449,032142,719,736H59,729,296 (ii) 20231231 20231231XVXV78352C3 20231231XV23336 (3)20231231(i)34.00%46.00%(ii)60.00%80.00%(i)(ii)(iii)(iv) (4)20231231(i)(ii)(iii)60193957.11% (5)20231231(i)(ii)40.00%40.00%20.00%202312317,776,0502,224,694(i)(ii) (6)H20231231202,449,032142,719,736H59,729,296 20231231XV23336 20211215B.3. 35 A 34 C1C.2.1 4965 C3 20231231 2023123118 2024612 2024662024612202465H1617 •• 20231231 •• 2024423 2023 20232024 I.2023 2023 II.2024 2024 2024423 ••••• C.2.1C.2.1(i)(ii) 20231231 20233303.09D 202312313.10(1)(2)3.10A 20231231 3.133.13 1112 20231231 C.1.4 20231231C.1.4 20231231 ••••••••3.10(2)3.13 20231231 C.5.1C.5.2C.5.3 20231231 20231231 10%50%(i)(ii)10% F.1.1 A.2.1 ••••• 20231231 C.4 3.21C.4D.33.10(2)3.21 (i)(ii)(iii)(iv)(v) 2023123120231231 • • • 3.25 (i)(ii)(iii)(iv)(v) 2023123120231231 ••• E.1.520231231 1,000,0001,000,0012,000,0002,000,0013,000,0003,000,0014,000,0004,000,0015,000,000 3.27 (i)(ii)(iii)(iv)(v) 2023123120231231 ••• 20231231 D.2.1D.2.4 • • • •• •20231231•108112 1231• (i)2023630(ii)20231231 • •20231231 3.292023123115 202312312023123175:58 5110% 563%10 841%3% 10 3(IR@luzhubiotech.com) 20231231 (www.luzhubiotech.com)(www.hkexnews.hk) 20231231 (ESG)ESG 20231120231231 C2ESG ESGESG 2023ESGESG 2023ESGI2022ESG ESG (ESG)ESG IR@luzhubiotech.com ESG ESGESGESGESG(EHS)ESG 2023ESG 200111 •LZ901CHO202183•K193(CD19-CD3)K193B2019129•-α(K3)201912IHumira••RSVRSV•K333(CD33-CD3)•K1932(CD19-CD3) •AIgG•CIgG•YIgG•W135IgG•BIgG •195•8••••• 1.1ESG EHSESGE